Protocol of the follow-up of patients with transthyretin amyloid cardiomyopathy by multimodality imaging (FAITH) study: a prospective observational study in patients with ATTR-CM undergoing treatment with tafamidis.

Gröschel J, Barzen G, Zernikow J, Blaszczyk E, Hahn K, Pernice HF, Sack I, Romero Dorta E, van Dijck P, Heidecker B, Schwenke C, Schulz-Menger J, Spethmann S

Open source

DOI
10.1136/bmjopen-2024-096397
Published
2025 Mar 22
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2024-096397,
  title = {Protocol of the follow-up of patients with transthyretin amyloid cardiomyopathy by multimodality imaging (FAITH) study: a prospective observational study in patients with ATTR-CM undergoing treatment with tafamidis.},
  author = {Gröschel J and Barzen G and Zernikow J and Blaszczyk E and Hahn K and Pernice HF and Sack I and Romero Dorta E and van Dijck P and Heidecker B and Schwenke C and Schulz-Menger J and Spethmann S},
  year = {2025},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2024-096397},
  url = {https://doi.org/10.1136/bmjopen-2024-096397}
}

RIS

TY  - JOUR
TI  - Protocol of the follow-up of patients with transthyretin amyloid cardiomyopathy by multimodality imaging (FAITH) study: a prospective observational study in patients with ATTR-CM undergoing treatment with tafamidis.
AU  - Gröschel J
AU  - Barzen G
AU  - Zernikow J
AU  - Blaszczyk E
AU  - Hahn K
AU  - Pernice HF
AU  - Sack I
AU  - Romero Dorta E
AU  - van Dijck P
AU  - Heidecker B
AU  - Schwenke C
AU  - Schulz-Menger J
AU  - Spethmann S
PY  - 2025
JO  - BMJ open
DO  - 10.1136/bmjopen-2024-096397
UR  - https://doi.org/10.1136/bmjopen-2024-096397
ER  - 

APA

J, G., G, B., J, Z., E, B., K, H., HF, P., I, S., E, R. D., P, V. D., B, H., C, S., J, S., & S, S. (2025). Protocol of the follow-up of patients with transthyretin amyloid cardiomyopathy by multimodality imaging (FAITH) study: a prospective observational study in patients with ATTR-CM undergoing treatment with tafamidis.. BMJ open. https://doi.org/10.1136/bmjopen-2024-096397

Source records